Salesforce Shares Slide as Soft Revenue Outlook Weighs on AI Momentum SoFi Technologies Reports Quarterly Results Market Awaits Detailed Financial Breakdown NASA Selects Blue Origin for Initial Uncrewed Lunar Mission in 20 Billion Moon Base Effort Global Infrastructure Funding Doubles in Five Years Japanese Banks Lead the Surge Workday Shares Rally 5 After Lifting Margin Forecast on AIDriven Efficiency Gains Wingstop Shares Decline After Earnings Miss Market Expectations Rio Tinto Q4 2025 Earnings EPS Misses Estimates Amid Challenging Commodity Environment Trane Technologies Q1 2026 Earnings EPS Beat Drives Modest Share Gains Amid Steady Operational Execution STXS Q1 2026 Earnings LargerThanExpected Loss as Company Continues Strategic Transition AMZN Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment REXR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency NICE Q1 2026 Earnings EPS Surpasses Estimates as Stock Declines INDO Stock Drops Over 11 Testing Key Support Levels BlackRock Taxable Municipal Bond Trust BBN Shows Modest Uptick as Price Hovers Near Midpoint of Key Range EpicQuest Education EEIQ Edges Lower Approaching Critical Support Zone WM Technology Inc MAPS Bounces 5 From Support Testing 041 Resistance Level Profound Medical Stock Dips 2 as Shares Test Key Support Levels Andy Burnhams Manchester Model A Regional Economic Philosophy That Could Shape UK Policy SCI Q1 2026 Earnings EPS Misses Estimates by 44 Shares Edge Higher FCF Consolidates Near Key Support Levels First Commonwealth Financial Holds Slight Gains ASC Q1 2026 Earnings Strong EPS Beat Amidst Operational Gains LTRN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Control as RD Pipeline Advances BIRD Q1 2026 Earnings EPS Misses Estimates as Losses Widen Six Flags Q1 2026 Earnings EPS Surprise Beats Estimates by Wide Margin Tower Semiconductor Ltd TSEM Q1 2026 Earnings Robust EPS Beat Highlights Operational Discipline Amid Revenue Uncertainty GXAI Q1 2026 Earnings EPS Misses Estimates as AI Development Continues Without Revenue Tenax Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Clinical Development